The estimated Net Worth of Autenried Paul Von is at least $11.1 Milhão dollars as of 22 November 2021. Mr. Von owns over 51,134 units of Bristol-Myers Squibb Co stock worth over $3,087,214 and over the last 13 years he sold BMY stock worth over $8,059,333. In addition, he makes $0 as Chief Information Officer e Senior Vice President at Bristol-Myers Squibb Co.
Paul has made over 26 trades of the Bristol-Myers Squibb Co stock since 2012, according to the Form 4 filled with the SEC. Most recently he sold 51,134 units of BMY stock worth $2,923,842 on 22 November 2021.
The largest trade he's ever made was exercising 56,212 units of Bristol-Myers Squibb Co stock on 4 February 2013 worth over $1,437,341. On average, Paul trades about 18,756 units every 127 days since 2012. As of 22 November 2021 he still owns at least 63,536 units of Bristol-Myers Squibb Co stock.
You can see the complete history of Mr. Von stock trades at the bottom of the page.
Paul von Autenried serves as Chief Information Officer, Senior Vice President of the Company. From 2012 to 2016 – Senior Vice President, Enterprise Services and Chief Information Officer, 2016 to 2019 – Senior Vice President, Chief Information Officer, 2019 to present – Executive Vice President, Chief Information Officer.
Paul Autenried is 58, he's been the Chief Information Officer e Senior Vice President of Bristol-Myers Squibb Co since 2016. There are 14 older and 20 younger executives at Bristol-Myers Squibb Co. The oldest executive at Bristol-Myers Squibb Co. is Vicki Sato, 71, who is the Lead Independent Director.
Autenried's mailing address filed with the SEC is BRISTOL-MYERS SQUIBB COMPANY, 430 E. 29TH STREET, 14 FLOOR, NEW YORK, NY, 10016.
Over the last 17 years, insiders at Bristol-Myers Squibb Co have traded over $318,151,721 worth of Bristol-Myers Squibb Co stock and bought 211,503 units worth $6,601,565 . The most active insiders traders include Lamberto Andreotti, James M Cornelius, eGiovanni Caforio. On average, Bristol-Myers Squibb Co executives and independent directors trade stock every 8 days with the average trade being worth of $1,682,720. The most recent stock trade was executed by Cari Gallman on 1 August 2024, trading 1,061 units of BMY stock currently worth $51,554.
The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the worlds largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.
Bristol-Myers Squibb Co executives and other stock owners filed with the SEC include: